Transcripts

ARS Pharmaceuticals (SPRY) earnings call transcripts

Earnings call transcripts for ARS Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.

Open SPRY in Gloom →
ARS Pharmaceuticals' chart, financials and news, free in your browser.Open SPRY in Gloom →
  • Q2 2026 earnings call

    The new CEO framed the quarter as a strategic reset toward provider-led growth, sharply lower spending, and a longer-term CSU opportunity.

    Aug 13, 2026Mildly positive0.35